Atherothrombosis risk factors
A comparison of the associations between seven hemostatic or inflammatory variables and coronary heart disease
Neonatal immune tolerance for hemophilia
High expression reduces an antibody response after neonatal gene therapy with B domain-deleted human factor VIII in mice
Multiple roles of the endothelial cell protein C receptor
Binding of factor VIIa to the endothelial cell protein C receptor reduces its coagulant activity
Antiphospholipid syndrome
Role of p38 mitogen-activated protein kinase in antiphospholipid antibody-mediated thrombosis and endothelial cell activation
Platelet function, antiplatelet therapy and clinical outcomes
Different methodologies for evaluating the effect of clopidogrel on platelet function in high-risk coronary artery disease patients
Efficacy of inferior vena cava filters in anticoagulated patients
Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery
Influence of thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 gene polymorphisms on tissue-type plasminogen activator-induced recanalization in ischemic stroke patients
Influence of age on the cost-effectiveness of diagnostic strategies for suspected pulmonary embolism
Prevention of catheter-related venous thrombosis with nadroparin in patients receiving chemotherapy for hematologic malignancies
Revised classification criteria for antiphospholipid syndrome and the thrombotic risk in patients with autoimmune diseases
Effect of leg exercises on popliteal venous blood flow during prolonged immobility of seated subjects
The plasma kallikrein–kinin system and risk of cardiovascular disease in men
Randomized, prospective clinical trial of recombinant factor VIIa for secondary prophylaxis in hemophilia patients with inhibitors
Challenges in defining type 2M von Willebrand disease
A collaborative study to establish the 1st International Standard for factor XIII plasma
A genetic basis for the interrelation of coagulation factors
Systemic administration of anti-urokinase plasminogen activator receptor monoclonal antibodies induces hepatic fibrin deposition in tissue-type plasminogen activator deficient mice
Proteomic analysis of platelet α-granules using mass spectrometry
Characterization of the interaction between von Willebrand factor and osteoprotegerin
Two novel monoclonal antibodies to VWFA3 inhibit VWF-collagen and VWF-platelet interactions
Scientific and standardization committee communications
Scott syndrome dogs have impaired coated-platelet formation and calcein-release but normal mitochondrial depolarization
The cost-effectiveness of warfarin pharmacogenomics
Effect of daptomycin on prothrombin time and the requirement for outlier exclusion in International Sensitivity Index calibration of thromboplastin
Mg2+ binding to the Gla domain of factor X influences the interaction with tissue factor
Current practise of testing for inherited thrombophilia
Phenotypic and genotypic differences in factor XII between African Americans and Caucasians
Influence of argatroban on coagulation parameters in heparin-induced thrombocytopenia patients after cardiothoracic surgery
Once-daily enoxaparin in pediatric thromboembolism
Altered fibrin clot structure in patients with advanced coronary artery disease
Outcome of the subsequent pregnancy after a first loss in women with factor V Leiden or prothrombin 20210A mutation
Outcome of the subsequent pregnancy after a first loss in women with the factor V Leiden or prothrombin 20210A mutation